What is the maximum recommended daily dose of doxepin for treating depression?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Maximum Dose of Doxepin for Depression

The maximum recommended daily dose of doxepin for treating depression is 300 mg/day, though additional therapeutic effect is rarely obtained by exceeding this dose. 1

Standard Dosing Algorithm

Initial Dosing

  • Starting dose: 75 mg/day for most patients with mild to moderate depression 1
  • Very mild cases: May start as low as 25-50 mg/day 1

Dose Titration

  • Usual optimum range: 75-150 mg/day 1
  • Severe depression: May require higher doses with gradual increase up to 300 mg/day 1
  • Maximum dose: 300 mg/day - rarely beneficial to exceed this 1

Dosing Schedule

  • Total daily dose can be given divided or once-daily 1
  • Once-daily maximum: 150 mg/day (given at bedtime) 1
  • The 150 mg capsule is for maintenance only, not treatment initiation 1

Important Clinical Considerations

Special Populations

Elderly patients: Should start at the low end of the dosing range due to increased risk of:

  • Decreased hepatic, renal, or cardiac function
  • Confusion and oversedation
  • Require close observation 1

Pharmacogenetic factors significantly impact dosing:

  • CYP2D6 poor metabolizers: Consider 50-60% dose reduction with therapeutic drug monitoring 2
  • CYP2D6 ultrarapid metabolizers: May require up to 200% of recommended dose 2
  • CYP2C19 ultrarapid/rapid metabolizers: May have suboptimal response; consider alternatives 2

Critical Safety Parameters

Cardiac monitoring is essential:

  • Obtain baseline ECG in patients over 40 years 3
  • Limit doses to <100 mg/day when possible in patients with cardiac disease 3
  • QRS prolongation indicates toxicity 1, 4

Therapeutic drug monitoring should be utilized when:

  • Doses exceed 150 mg/day
  • Patient is elderly or has comorbidities
  • Genetic polymorphisms are present
  • Drug interactions exist 2, 5

Common Pitfalls to Avoid

  1. Exceeding 300 mg/day: No additional benefit and increased toxicity risk 1
  2. Rapid titration: Increase gradually by 10-25 mg increments every 5-7 days 6
  3. Ignoring drug interactions: CYP2D6 and CYP2C19 inhibitors (e.g., clobazam, topiramate) can precipitate toxicity even at standard doses 4
  4. Inadequate trial duration: Allow 6-8 weeks including 2 weeks at maximum tolerated dose before declaring treatment failure 3

Real-World Dosing Patterns

Research shows that low-dose treatment is common in practice, with mean doses around 83 mg/day 7. Physicians adaptively adjust doses based on:

  • Age (elderly: 68 mg/day vs. younger: 84 mg/day)
  • Gender (males: 94 mg/day vs. females: 79 mg/day)
  • Depression severity (mild: 68 mg/day vs. moderate-severe: 100 mg/day) 7

While 300 mg/day is the FDA-approved maximum, clinical practice often uses lower doses (75-150 mg/day) with good efficacy and improved tolerability. 1, 7

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.